Tag: MHRA
UK Regulators Issue Five Medical Device Safety Alerts in Mid-June 2026
The UK Medicines and Healthcare products Regulatory Agency (MHRA) issued five field safety notices between 15 and 19 June 2026,…
UK Orphan Drug Registry Expands Access to Rare Disease Treatments
The UK Medicines and Healthcare products Regulatory Agency (MHRA) maintains a comprehensive registry of authorised orphan medicinal products for rare…
UK Regulators Issue Warning on Unlicensed Weight-Loss Drugs and False Marketing Claims
UK regulators have issued a joint warning against businesses promoting unlicensed weight-loss medicines and newly authorised prescription drugs with false…
UK and US Regulators Launch Joint Liaison Programme to Strengthen Drug Approval Coordination
The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) have launched a formal…
MHRA Approves First Needle-Free Adrenaline Nasal Spray for Young Children
UK regulators approve the first needle-free adrenaline nasal spray for children as young as 12 months, offering a breakthrough treatment…
MHRA’s Top Scientist Dr Nicola Rose Receives OBE for Public Health Leadership
Dr Nicola Rose, MHRA's Executive Director of Science and Research, receives OBE in 2026 King's Birthday Honours for contributions to…
MHRA Publishes Updated List of Medical Devices with Exceptional Use Authorisations
MHRA releases updated registry of medical devices with exceptional use authorisations, documenting both active and expired emergency regulatory exemptions. The…
UK Health Regulator Issues Class 4 Alert for Denosumab Injection Labelling Error
MHRA issues Class 4 alert for Ponlimsi denosumab after Teva UK reports carton labelling error stating "For application to the…